CastleKnight Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History
Bought
Maintained
Sold
Other funds holding LHDX
ECG
EV
AA
BCM
LRPA
CWA
CastleKnight Management's LHDX Position: Q3 2022 in Review
CastleKnight Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 66,700 shares — an estimated $124K sold.
CastleKnight Management first reported a position in LHDX in Q4 2021 and held it in 3 quarters. The position peaked at $238K in Q1 2022. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.
- CastleKnight Management reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- CastleKnight Management sold 66,700 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $124K.
- CastleKnight Management first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
- CastleKnight Management's Lucira Health, Inc. Common Stock position peaked at $238K in Q1 2022.
- 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.
Based on CastleKnight Management's 13F filing for Q3 2022, filed 14 Nov 2022.